Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-((allylthio)methyl)-6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
2. Altizide
3. Altozide
1. Altizide
2. 5588-16-9
3. (-)-altizide
4. Altizide, (+)-
5. (+)-altizide
6. Althiazide [usan]
7. Altizide, (-)-
8. 6-chloro-3,4-dihydro-3-[(2-propenylthio)methyl]-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
9. Altizide [inn]
10. 3-((allylthio)methyl)-6-chloro-3,4-dihydro-2h-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide
11. D9kls88blv
12. 133562-97-7
13. 133585-76-9
14. Nsc-757786
15. Gi8cb72b0d
16. Ji3zo158in
17. 2h-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-((2-propen-1-ylthio)methyl)-, 1,1-dioxide, (+)-
18. 2h-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-((2-propen-1-ylthio)methyl)-, 1,1-dioxide, (-)-
19. P-1779
20. Altizide (inn)
21. Althiazide (usan)
22. Ncgc00094855-01
23. Altizida
24. Dsstox_cid_25857
25. Dsstox_rid_81178
26. Dsstox_gsid_45857
27. 2h-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-((2-propenylthio)methyl)-, 1,1-dioxide
28. 3-((allylthio)methyl)-6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
29. 3-[(allylthio)methyl]-6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
30. Altizidum
31. Altizidum [inn-latin]
32. Sr-05000001753
33. Altizida [inn-spanish]
34. Unii-d9kls88blv
35. Unii-gi8cb72b0d
36. Unii-ji3zo158in
37. Althiazide-[d5]
38. Prestwick_43
39. 6-chloro-1,1-dioxo-3-(prop-2-enylsulfanylmethyl)-3,4-dihydro-2h-1lambda6,2,4-benzothiadiazine-7-sulfonamide
40. Cas-5588-16-9
41. Einecs 226-994-8
42. Cb 8093
43. Spectrum_001104
44. Starbld0016521
45. Specplus_000833
46. Prestwick0_000721
47. Prestwick1_000721
48. Prestwick2_000721
49. Prestwick3_000721
50. Spectrum2_001367
51. Spectrum3_000902
52. Spectrum4_000999
53. Spectrum5_001725
54. Altizide [mart.]
55. Altizide [who-dd]
56. P 1779
57. Bspbio_000642
58. Kbiogr_001437
59. Kbioss_001584
60. Mls002153973
61. Divk1c_001031
62. Divk1c_006929
63. Schembl124525
64. Spectrum1500804
65. Spbio_001294
66. Spbio_002581
67. Altizide [ep Impurity]
68. Bpbio1_000708
69. Chembl599870
70. Altizide [ep Monograph]
71. Dtxsid3045857
72. Chebi:91768
73. Hms503o03
74. Kbio1_001031
75. Kbio1_001873
76. Kbio2_001584
77. Kbio2_004152
78. Kbio2_006720
79. Kbio3_001844
80. Ninds_001031
81. Hms1570a04
82. Hms1921i12
83. Hms2092k18
84. Hms2097a04
85. Hms2233o21
86. Hms3373k04
87. Hms3714a04
88. Pharmakon1600-01500804
89. Hy-b1254
90. Tox21_111347
91. Ccg-38982
92. Nsc757786
93. Akos027381757
94. Tox21_111347_1
95. Nsc 757786
96. 3-allylthiomethyl-6-chlor-3,4-dihydro-2h-1,2,4-benzothiadiazin-7-sulfonamid 1,1-dioxid
97. Idi1_001031
98. Smp1_000012
99. Ncgc00094855-02
100. Ncgc00094855-03
101. Ncgc00094855-06
102. 2h-1,2,4-benzothiadiazine-7-sulfonamide,6-chloro-3,4-dihydro-3-[(2-propen-1-ylthio)methyl]-, 1,1-dioxide
103. 6-chloro-3,4-dihydro-3-[(2-propen-1-ylthio)methyl]-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
104. Smr001233310
105. Sbi-0052594.p002
106. Db-052814
107. Ab00053099
108. Cs-0013046
109. Ft-0635778
110. D02838
111. Ab00053099_08
112. Sr-05000001753-1
113. Sr-05000001753-3
114. Brd-a56675431-001-04-0
115. Brd-a56675431-001-07-3
116. Altizide, European Pharmacopoeia (ep) Reference Standard
117. 6-chloro-3,4-dihydro-3-((2-propenylthio)methyl)-2h-1,2,4-benzothiadiazine-7-sulfonamide
118. 2h-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[(2-propen-1-ylthio)methyl]-, 1,1-dioxide
119. 6-chloro-1,1-dioxo-3-[(prop-2-enylthio)methyl]-3,4-dihydro-2h-1$l;{6},2,4-benzothiadiazine-7-sulfonamide
120. 6-chloro-3,4-dihydro-3-[(2-propenylthio)methyl]-2h-1,2,4-benzothiadiazine-7-sulfonamide1,1-dioxide
Molecular Weight | 383.9 g/mol |
---|---|
Molecular Formula | C11H14ClN3O4S3 |
XLogP3 | 0.8 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 5 |
Exact Mass | 382.9834972 g/mol |
Monoisotopic Mass | 382.9834972 g/mol |
Topological Polar Surface Area | 160 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 614 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
C03EA04
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?